Reversine (A3760): Practical Workflow Guide for Aurora Kinase Inhibition

What This Product Solves

Reversine (6-N-cyclohexyl-2-N-(4-morpholin-4-ylphenyl)-7H-purine-2,6-diamine), available as Reversine (SKU A3760), is a small molecule inhibitor designed for researchers investigating the Aurora kinase signaling pathway in cancer biology. Aurora kinases A, B, and C are serine/threonine kinases essential for mitotic regulation, controlling processes such as centrosome maturation, microtubule-kinetochore attachment, and cell cycle progression. Targeted inhibition of these kinases with Reversine allows direct interrogation of mitotic checkpoint control and is especially relevant for studies on cancer cell proliferation inhibition and apoptosis induction in cancer cells.

This product addresses the need for a cell-permeable Aurora kinase inhibitor with a defined inhibition profile and reliable solubility in organic solvents. Researchers focused on cervical cancer research or workflows requiring precise manipulation of the Aurora kinase A/B/C axis will find it particularly useful. Applications include in vitro cell cycle assays, assessment of apoptosis, and in vivo tumor proliferation studies in murine models. However, Reversine is not intended for diagnostic or clinical use, nor for protocols requiring aqueous solubility or long-term storage in solution.

Protocol Parameters

• Assay: Aurora kinase inhibition (in vitro cell culture)
  Value with unit: IC50: Aurora A = 150 nM; Aurora B = 500 nM; Aurora C = 400 nM
  Applicability: Use as a reference concentration range for initial screening and dose-response in cell-based assays.
  Rationale: Enables targeted interrogation of Aurora kinase A, B, and C activities in mitotic checkpoint studies.
  Source type: Product information
• Assay: Compound solubilization for stock preparation
  Value with unit: Soluble in DMSO (≥19.65 mg/mL); soluble in ethanol (≥6.69 mg/mL with gentle warming and ultrasonic treatment); insoluble in water.
  Applicability: Preparation of concentrated stocks for in vitro or in vivo dosing.
  Rationale: Ensures full dissolution and accurate dosing; avoids precipitation in working solutions.
  Source type: Product information
• Assay: Storage and handling
  Value with unit: Store solid at -20°C; avoid long-term storage of solutions.
  Applicability: Maintains compound stability and reproducibility between experiments.
  Rationale: Prevents degradation and potency loss; solution stocks should be freshly prepared before use.
  Source type: Product information
• Assay: Recommended working concentration (cell-based assays)
  Value with unit: 0.5–5 μM (recommendation based on typical Aurora kinase inhibitor practices, adjust empirically)
  Applicability: Starting point for titration in cell proliferation or apoptosis assays.
  Rationale: Empirical optimization is required as sensitivity varies by cell line and context.
  Source type: Workflow recommendation

Workflow Setup and QC Checklist

• Compound Handling: Upon receipt, verify that the powder is intact and shipped on blue ice. Store immediately at -20°C.
• Stock Solution Preparation: Dissolve Reversine in DMSO (preferred) or ethanol (with warming and ultrasonic treatment). Check for complete dissolution before aliquoting.
• Aliquoting: Prepare single-use aliquots to minimize freeze-thaw cycles. Label aliquots with date and concentration.
• Working Solution Preparation: Dilute stock into cell culture medium immediately before use. Confirm final solvent concentration does not exceed cell viability thresholds (typically <0.1% DMSO for most cell lines).
• QC Check: Visually inspect for precipitation after dilution. Discard any turbid or precipitated solutions.
• Control Design: Include vehicle-only controls (DMSO or ethanol) and, if available, a positive control Aurora kinase inhibitor for benchmarking.

Common Failure Modes and Fixes

• Incomplete Dissolution: If powder persists after mixing, increase temperature slightly and use ultrasonic treatment (for ethanol). Do not exceed recommended solvent volumes.
• Precipitation in Media: If precipitation occurs on dilution, reduce stock concentration or add stock slowly with constant mixing. Always filter sterilize if sterility is required.
• Loss of Activity: If expected biological effects are not observed, check storage conditions and preparation history. Prepare fresh stock and repeat assay.
• Solvent Toxicity: If cells show unexpected toxicity, titrate down the final DMSO/ethanol concentration. Consider parallel vehicle controls to distinguish compound-specific effects.
• Batch-to-Batch Variability: For repeat experiments, use the same lot and document all handling steps. If changing lots, revalidate with a small-scale test.

Scope and Limitations

Reversine is validated for the inhibition of Aurora kinase A, B, and C in both in vitro and murine in vivo models, supporting studies on mitotic progression, cell cycle regulation, and apoptosis induction in cancer cells. Its specific solubility profile—soluble in DMSO and ethanol, but not water—limits its use in aqueous or high-throughput screening protocols that require water-based delivery. The compound is not suitable for diagnostic, medical, or clinical workflows. Long-term storage in solution is not recommended due to stability concerns; solid material should be stored at -20°C and solutions made fresh for each experiment.

Mechanistic claims should be confined to established inhibition of Aurora kinases as described in the product dossier. Researchers are advised to empirically optimize concentrations and confirm effects in their specific system. For advanced guidance on assay design and troubleshooting, internal articles such as this scenario-driven guide and this workflow optimization article provide context-specific recommendations and troubleshooting tips.

Conclusion

Reversine (A3760) is a practical, well-characterized Aurora kinase inhibitor for research on mitotic regulation and cancer cell fate. Its defined inhibition profile, solubility in DMSO and ethanol, and suitability for both in vitro and in vivo use make it a versatile reagent for studies involving the Aurora kinase signaling pathway and cancer cell proliferation inhibition. By adhering to recommended storage, solubilization, and assay protocols, researchers can achieve reproducible results and minimize confounding variables. For further protocol and troubleshooting support, refer to the APExBIO product page and the referenced internal articles.